Tower Research Capital (TRC)’s JPMorgan US Quality Factor ETF JQUA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-15,341
Closed -$868K 5854
2024
Q3
$868K Buy
+15,341
New +$833K 0.02% 603
2024
Q1
Sell
-6,190
Closed -$296K 6016
2023
Q4
$296K Buy
6,190
+5,231
+545% +$235K ﹤0.01% 1783
2023
Q3
$41.5K Buy
+959
New +$42.8K ﹤0.01% 2701
2023
Q2
Sell
-978
Closed -$40K 6217
2023
Q1
$40K Sell
978
-1,234
-56% -$49.5K ﹤0.01% 2708
2022
Q4
$86K Sell
2,212
-9,503
-81% -$365K ﹤0.01% 1951
2022
Q3
$410K Buy
11,715
+6,560
+127% +$253K 0.01% 1293
2022
Q2
$192K Sell
5,155
-7,282
-59% -$289K ﹤0.01% 1791
2022
Q1
$533K Sell
12,437
-1,211
-9% -$51.1K 0.01% 1111
2021
Q4
$621K Buy
13,648
+7,785
+133% +$340K 0.01% 965
2021
Q3
$240K Sell
5,863
-3,676
-39% -$155K 0.01% 1642
2021
Q2
$390K Sell
9,539
-953
-9% -$37.8K 0.01% 1380
2021
Q1
$396K Buy
+10,492
New +$384K 0.01% 1429

Other funds holding JQUA

Tower Research Capital (TRC)'s JQUA Position: Q4 2024 in Review

Tower Research Capital (TRC) sold out of JPMorgan US Quality Factor ETF (JQUA) in Q4 2024, closing a stake of 15,341 shares — an estimated $868K sold.

Tower Research Capital (TRC) first reported a position in JQUA in Q1 2021 and held it in 12 quarters. The position peaked at $868K in Q3 2024. 375 funds tracked by Wall St. Rank hold JQUA as of Q4 2024.

  • Tower Research Capital (TRC) reported no remaining JPMorgan US Quality Factor ETF position as of Q4 2024 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 15,341 JPMorgan US Quality Factor ETF shares in Q4 2024, an estimated $868K.
  • Tower Research Capital (TRC) first reported a position in JPMorgan US Quality Factor ETF in Q1 2021 and held it in 12 quarters.
  • Tower Research Capital (TRC)'s JPMorgan US Quality Factor ETF position peaked at $868K in Q3 2024.
  • 375 funds tracked by Wall St. Rank held JPMorgan US Quality Factor ETF as of Q4 2024.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2024, filed 13 Feb 2025.